Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: A gene expression profiling study with implications for potential combination therapies-Reference-Cited by-同舟云学术

Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: A gene expression profiling study with implications for potential combination therapies

Published:2008-02 Issue:2 Volume:32 Page:275-285
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Zhao Xiaoxian,Qiu Wansong,Kung Jiachun,Zhao Xinyu,Peng Xuejun,Yegappan Mani,Yen-Lieberman Belinda,Hsi Eric D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference65 articles.

1. Hodgkin and Reed–Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells;Kanzler;J Exp Med,1996

2. Hodgkin disease: Hodgkin and Reed–Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development;Kuppers;Proc Natl Acad Sci USA,1994

3. Hodgkin and Reed–Sternberg cells represent an expansion of a single clone originating from a germinal center B cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription;Marafioti;Blood,2000

4. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells;Bargou;J Clin Invest,1997

5. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed–Sternberg cells;Emmerich;Blood,1999

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities;Oncotarget;2017-11-01

2. Combined therapeutic effects of bortezomib and anacardic acid on multiple myeloma cells via activation of the endoplasmic reticulum stress response;Molecular Medicine Reports;2016-07-19

3. Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells;Immunopharmacology and Immunotoxicology;2015-12-15

4. Prognostic Biomarkers for Hodgkin Lymphoma;Pediatric Hematology and Oncology;2015-09-18

5. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo;Toxicology Letters;2014-01